Characterization of the SF3B1-SUGP1 interface reveals how numerous cancer mutations cause mRNA missplicing

Genes Dev. 2023 Dec 26;37(21-24):968-983. doi: 10.1101/gad.351154.123.

Abstract

The spliceosomal gene SF3B1 is frequently mutated in cancer. While it is known that SF3B1 hotspot mutations lead to loss of splicing factor SUGP1 from spliceosomes, the cancer-relevant SF3B1-SUGP1 interaction has not been characterized. To address this issue, we show by structural modeling that two regions flanking the SUGP1 G-patch make numerous contacts with the region of SF3B1 harboring hotspot mutations. Experiments confirmed that all the cancer-associated mutations in these regions, as well as mutations affecting other residues in the SF3B1-SUGP1 interface, not only weaken or disrupt the interaction but also alter splicing similarly to SF3B1 cancer mutations. Finally, structural modeling of a trimeric protein complex reveals that the SF3B1-SUGP1 interaction "loops out" the G-patch for interaction with the helicase DHX15. Our study thus provides an unprecedented molecular view of a protein complex essential for accurate splicing and also reveals that numerous cancer-associated mutations disrupt the critical SF3B1-SUGP1 interaction.

Keywords: AlphaFold-Multimer; DHX15; G-patch; myelodysplastic syndromes; spliceosome mutations.

MeSH terms

  • Humans
  • Mutation
  • Neoplasms* / genetics
  • Neoplasms* / metabolism
  • Phosphoproteins / metabolism
  • RNA Splicing / genetics
  • RNA Splicing Factors / chemistry
  • RNA, Messenger / metabolism
  • Spliceosomes* / genetics
  • Spliceosomes* / metabolism

Substances

  • RNA, Messenger
  • RNA Splicing Factors
  • Phosphoproteins
  • SUGP1 protein, human
  • SF3B1 protein, human